(2) Active non-implantable devices for imaging, monitoring and/or diagnosis

Size: px
Start display at page:

Download "(2) Active non-implantable devices for imaging, monitoring and/or diagnosis"

Transcription

1 ANNEX I The list of codes and corresponding types of devices for the purpose of specifying the scope of the designation as notified bodies in the field of medical devices under Regulation (EU) 2017/745 I CODES REFLECTING THE DESIGN AND PURPOSE OF THE DEVICE A) ACTIVE DEVICES (1) Active implantable devices MDA CODE Active implantable devices MDA 0101 MDA 0102 MDA 0103 MDA 0104 Active implantable devices for stimulation / inhibition / monitoring Active implantable devices delivering drugs or other substances Active implantable devices substituting or replacing organ functions Active implantable devices utilising radiation and other active implantable devices (2) Active non-implantable devices for imaging, monitoring and/or diagnosis MDA CODE Active non-implantable devices for imaging, monitoring and/or diagnosis MDA 0201 MDA 0202 MDA 0203 MDA 0204 Active non-implantable imaging devices utilising ionizing radiation Active non-implantable imaging devices utilising non-ionizing radiation Active non-implantable devices for monitoring of vital physiological parameters Other active non-implantable devices for monitoring and/or diagnosis (3) Active non-implantable therapeutic devices and general active non-implantable devices MDA CODE Active non-implantable therapeutic devices and general active non-implantable devices MDA 0301 MDA 0302 MDA 0303 MDA 0304 MDA 0305 MDA 0306 MDA 0307 MDA 0308 MDA 0309 MDA 0310 MDA 0311 Active non-implantable devices utilising ionizing radiation Active non-implantable devices utilising non-ionizing radiation Active non-implantable devices utilising hyperthermia / hypothermia Active non-implantable devices for shock-wave therapy (lithotripsy) Active non-implantable devices for stimulation or inhibition Active non-implantable devices for extra-corporal circulation, administration or removal of substances and haemopheresis Active non-implantable respiratory devices Active non-implantable devices for wound and skin care Active non-implantable ophthalmologic devices Active non-implantable devices for ear, nose and throat Active non-implantable dental devices Komentář [VP1]: The definitions using the word other for remaining products not specifically mentioned in the list is unsuitable with regard to purpose of the list. According to the Article 2 of the proposed regulation, the Conformity assessment bodies (CAB) shall use the lists of codes when specifying the types of devices in the application for designation. However, the application shall be substantiated by an evidence of the CAB personnel qualification related to each code applied for. A proof of qualification in terms of educational branch, specific training and experience with assessment of precisely specified devices (e.g. MDA 0201 Active non-implantable imaging devices utilising ionizing radiation) can be submitted relatively easily. However a problem occurs whenever CAB applies for uncertain categories like MDN 1214 General non-active nonimplantable devices used in health care and other non-active non-implantable devices. What kind of education, what kind of training, what kind of experience with auditing and documentation assessment shall be submitted by notified body together with the application? How will be assessed the CAB s qualification for these uncertain categories/codes in course of a joint assessment? Answer to the above question is not easy. For this reason we recommend strongly to replace the uncertain categories/codes by one or more codes covering the remaining medical devices not mentioned already. Komentář [VP2]: See comment VP1 EN 1 EN

2 MDA 0312 MDA 0313 MDA 0314 MDA 0315 MDA 0316 MDA 0317 MDA 0318 Other active non-implantable surgical devices Active non-implantable prostheses, devices for rehabilitation and devices for patient positioning and transport Active non-implantable devices for processing and preservation of human cells, tissues or organs including in vitro fertilisation (IVF) and assisted reproductive technologies (ART) Standalone software B) Non-active devices Medical gas supply systems and parts thereof Active non-implantable devices for cleaning, disinfection and sterilisation Other active non-implantable devices (1) Non-active implants and long term surgically invasive devices MDN CODE Non-active implants and long term surgically invasive devices MDN 1101 MDN 1102 MDN 1103 MDN 1104 Non-active cardiovascular, vascular and neurovascular implants Non-active osteo- and orthopaedic implants Non-active dental implants and dental materials Non-active soft tissue and other implants Komentář [VP3]: A more detailed explanation should be suitable. For example: There is not clear, whether gas supply system covers whole gas distribution piping system being permanent part of the building, or only the piping from the wall outlet to a medical device administering the medicinal gas to the patient body. Komentář [VP4]: See the comment VP1 Komentář [VP5]: A specific category MDN 1105 Non-active ocular implants should be added covering intraocular lenses, long term contact lenses, orbital implants etc. Komentář [VP6]: See the comment VP1 (2) Non-active non-implantable devices MDN CODE Non-active non-implantable devices MDN 1201 MDN 1202 MDN 1203 MDN 1204 MDN 1205 MDN 1206 MDN 1207 MDN 1208 MDN 1209 MDN 1210 MDN 1211 MDN 1212 MDN 1213 MDN 1214 Non-active non-implantable devices for anaesthesia, emergency and intensive care Non-active non-implantable devices for administration, channelling and removal of substances, including devices for dialysis Non-active non-implantable guide catheters, balloon catheters, guidewires, introducers, filters, and related tools Non-active non-implantable devices for wound and skin care Non-active non-implantable orthopaedic and rehabilitation devices Non-active non-implantable ophthalmologic devices Non-active non-implantable diagnostic devices Non-active non-implantable instruments Non-active non-implantable dental materials Non-active non-implantable devices used for contraception or prevention of the transmission of sexually transmitted diseases Non-active non-implantable devices for disinfecting, cleaning and rinsing Non-active non-implantable devices for processing and preservation of human cells, tissue or organs including in vitro fertilisation (IVF) and assisted reproductive technologies (ART) Non-active non-implantable devices composed of substances to be introduced into the human body via a body orifice or the dermal route General non-active non-implantable devices used in health care and other non-active nonimplantable devices Komentář [VP7]: This specification is not unambiguous one. It could cover either devices for disinfecting, cleaning and rinsing of medical devices and surfaces of an operating theatre or devices for disinfecting, cleaning and rinsing of wounds and patient s skin. Komentář [VP8]: See the comment VP1 plus the following general remark: Generally, the need for explanation and examples of devices in certain or all categories/codes is apparent. Depending on point of view, lot of medical devices could be assigned to different MDA or MDN codes. In order to prevent such unwanted situation, an ANNEX III with examples of medical devices belonging to certain codes shall be added to this Regulation. EN 2 EN

3 II HORIZONTAL CODES (1) Devices with specific characteristics MDS CODE MDS 1001 MDS 1002 MDS 1003 Devices with specific characteristics Devices incorporating medicinal substances Devices manufactured utilising tissues or cells of animal origin, or their derivatives Devices manufactured utilising tissues or cells of human origin, or their derivatives MDS 1004 Devices which are also machinery as defined in point (a) of the second paragraph of Article 2 of Directive 2006/42/EC of the European Parliament and of the Council 1 MDS 1005 MDS 1006 MDS 1007 MDS 1008 MDS 1009 MDS 1010 MDS 1011 MDS 1012 MDS 1013 MDS 1014 Devices in sterile condition Reusable surgical instruments Devices incorporating or consisting of nanomaterial Devices utilising biological active coatings and / or materials or being wholly or mainly absorbed or locally dispersed in the human body or are intended to undergo a chemical change in the body Devices incorporating software / utilising software / controlled by software, including devices intended for controlling, monitoring or directly influencing the performance of active or active implantable devices Devices with a measuring function Devices in systems or procedure packs Products without an intended medical purpose listed in Annex XVI to Regulation (EU) 2017/745 Class III custom-made implantable devices Devices incorporating as an integral part an in vitro diagnostic device Komentář [VP9]: An explanation would be necessary, whether or not the firmware written on memory chips (ROM EPROM etc.) being integrated parts of the device is also belonging to this category. (2) Devices for which specific technologies or processes have been used 1 MDT CODE Devices for which specific technologies or processes have been used MDT 2001 MDT 2002 MDT 2003 MDT 2004 MDT 2005 MDT 2006 MDT 2007 MDT 2008 Devices which require metal processing Devices which require plastic processing Devices which require non-metal mineral processing such as glass, ceramics Devices which require non-metal non-mineral processing such as textiles, rubber, leather, paper Devices which require the use of biotechnology Devices which require chemical processing Devices which require the production of pharmaceuticals or knowledge regarding the production of pharmaceuticals Devices which require clean room production Directive 2006/42/EC of the European Parliament and of the Council of 17 May 2006 on machinery, and amending Directive 95/16/EC (recast) (OJ L , p. 24). Komentář [VP10]: Rubber shall belong rather to the MDT 2002 Devices which require plastics and rubber processing, because chemically the same polymer can appear in plastic and elastic state, in dependency on the temperature and shear stress applied. (look on the literature regarding viscoelasticity and viscoelastic behaviour). Therefore, the separating of plastics and rubber into different codes is incorrect. Komentář [VP11]: Certain duplicity with the code MDS 1001 EN 3 EN

4 MDT 2009 MDT 2010 MDT 2011 MDT 2012 MDT 2013 Devices which require processing of materials of human or animal origin Devices which require manufacture or processing of electronic components including communication devices Devices which require packaging, including labelling Devices which require installation, refurbishment Devices which have undergone reprocessing EN 4 EN

5 ANNEX II The list of codes and corresponding types of devices for the purpose of specifying the scope of the designation as notified bodies in the field of in vitro diagnostic medical devices under Regulation (EU) 2017/746 I CODES REFLECTING THE DESIGN AND PURPOSE OF THE DEVICE (1) Devices intended to be used for blood grouping IVR 0101 IVR 0102 IVR 0103 IVR 0104 IVR 0105 IVR 0106 Devices intended to be used for blood grouping to ensure the immunological compatibility of blood, blood components, cells, tissue or organs that are intended for transfusion or transplantation or cell administration Devices intended to be used for blood grouping with regard to ABO system [A (ABO1), B (ABO2), AB (ABO3)] Devices intended to be used for blood grouping with regard to Rhesus system [RH1 (D), RHW1, RH2 (C), RH3 (E), RH4 (c), RH5 (e)] Devices intended to be used for blood grouping with regard to Kell system [Kel1 (K)] Devices intended to be used for blood grouping with regard to Kidd system [JK1 (Jka), JK2 (Jkb)] Devices intended to be used for blood grouping with regard to Duffy system [FY1 (Fya), FY2 (Fyb)] Other devices for blood grouping to ensure the immunological compatibility of blood, blood components, cells, tissue or organs that are intended for transfusion or transplantation or cell administration, referred to in point 2.2 (rule 2) of Annex VIII to Regulation (EU) 2017/746 Other devices intended to be used for blood grouping IVR 0107 Devices intended to be used for blood grouping, other than those referred to in point 2.2 (rule 2) of Annex VIII to Regulation (EU) 2017/746 Komentář [VP12]: See comment VP1 (2) Devices intended to be used for tissue typing IVR 0201 IVR 0202 IVR 0203 Devices intended to be used for tissue typing Devices intended to be used for tissue typing to ensure the immunological compatibility of blood, blood components, cells, tissue or organs that are intended for transfusion or transplantation or cell administration (HLA A, B, DR) Other devices intended to be used for tissue typing to ensure the immunological compatibility of blood, blood components, cells, tissue or organs that are intended for transfusion or transplantation or cell administration, referred to in point 2.2 (rule 2) of Annex VIII to Regulation (EU) 2017/746 Devices intended to be used for tissue typing, other than those referred to in point 2.2 (rule 2) of Annex VIII to Regulation (EU) 2017/746 Komentář [VP13]: See comment VP1 EN 5 EN

6 (3) Devices intended to be used for markers of cancer and non-malignant tumours IVR 0301 Devices intended to be used for markers of cancer and non-malignant tumours except devices for human genetic testing Devicesintended to be used in screening, diagnosis, staging or monitoring of cancer IVR 0302 Other devices intended to be used for markers of cancer and non-malignant tumours (4) Devices intended to be used for human genetic testing Komentář [VP14]: The category description Devices intended to be used in screening, diagnosis, staging or monitoring of non-malignant tumours is more suitable, because the IVR 0301 deals with the cancer already. IVR 0401 IVR 0402 IVR 0403 Devices intended to be used for human genetic testing Devices intended to be used in screening / confirmation of congenital / inherited disorders Devices intended to be used to predict genetic disease risk and prognosis Other devices intended to be used for human genetic testing Komentář [VP15]: See VP1 (5) Devices intended to be used to determine markers of infections / immune status IVR 0501 IVR 0502 IVR 0503 IVR 0504 IVR 0505 IVR 0506 Devices intended to be used for the screening, confirmation, identification of infectious agents or determination of immune status Devices intended to be used for pre-natal screening of women in order to determine their immune status towards transmissible agents Devices intended to be used to detect the presence of, or exposure to transmissible agents in blood, blood components, cells, tissues or organs, or in any of their derivatives, to assess their suitability for transfusion, transplantation or cell administration Devices intended to be used to detect the presence of, or exposure to an infectious agent including sexually transmitted agents Devices intended to be used to determine the infectious load, to determine infective disease status or immune status and devices used for infectious disease staging Devices intended to be used to grow / isolate / identify and handle infectious agents Other devices intended to be used to determine markers of infections / immune status Komentář [VP16]: See VP1 (6) Devices intended to be used for non-infectious pathologies, physiological markers, and disorders / impairments (except human genetic testing) IVR 0601 IVR 0602 IVR 0603 Devices intended to be used for a specific disease Devices intended to be used for screening / confirmation of specific disorders / impairments Devices intended to be used for screening, determination or monitoring of physiological markers for a specific disease Devices intended to be used for screening, confirmation / determination, or monitoring of allergies and intolerances EN 6 EN

7 IVR 0604 IVR 0605 IVR 0606 IVR 0607 IVR 0608 IVR 0609 Other devices intended to be used for a specific disease Devices intended to be used to define or monitor physiological status and therapeutic measures Devices intended to be used for monitoring of levels of medicinal products, substances or biological components Devices intended to be used for non-infectious disease staging Devices intended to be used for detection of pregnancy or fertility testing Devices intended to be used for screening, determination or monitoring of physiological markers Other devices intended to be used to define or monitor physiological status and therapeutic measures Komentář [VP17]: See VP1 Komentář [VP18]: See VP1 (7) Devices which are controls without a quantitative or qualitative assigned value IVR 0701 IVR 0702 Controls without a quantitative or qualitative assigned value Devices which are controls without a quantitative assigned value Devices which are controls without a qualitative assigned value (8) Class A devices in sterile condition IVR 0801 IVR 0802 IVR 0803 Class A devices in sterile condition Devices referred to in point 2.5 (rule 5), under a), of Annex VIII to Regulation (EU) 2017/746 Instruments intended specifically to be used for in vitro diagnostic procedures referred to in point 2.5 (rule 5), under b), of Annex VIII to Regulation (EU) 2017/746 Specimen receptacles referred to in point 2.5 (rule 5), under c), of Annex VIII to Regulation (EU) 2017/746 II HORIZONTAL CODES (1) In vitro diagnostic devices with specific characteristics IVS CODE IVS 1001 IVS 1002 IVS 1003 IVS 1004 In vitro diagnostic devices with specific characteristics Devices intended to be used for near-patient testing Devices intended to be used for self-testing Devices intended to be used as companion diagnostics Devices utilizing material of human origin EN 7 EN

8 IVS 1005 Devices in sterile condition IVS 1006 Calibrators (point 1.5 of Annex VIII to Regulation (EU) 2017/746) IVS 1007 IVS 1008 IVS 1009 Control materials with quantitative or qualitative assigned values intended for one specific analyte or multiple analytes (point 1.6 of Annex VIII to Regulation (EU) 2017/746) Instruments, equipment, systems or apparatus Software independent of any other device including software apps, software for data analysis, and for defining or monitoring therapeutic measures IVS 1010 Devices incorporating software / utilising software / controlled by software (2) In vitro diagnostic devices for which specific technologies have been used Komentář [VP19]: An explanation would be necessary, whether or not the firmware written on memory chips (ROM EPROM etc.) being integrated parts of the device is also belonging to this category. IVT CODE IVT 2001 IVT 2002 IVT 2003 IVT 2004 IVT 2005 IVT 2006 IVT 2007 IVT 2008 IVT 2009 IVT 2010 IVT 2011 In vitro diagnostic devices for which specific technologies have been used In vitro diagnostic devices which require metal processing In vitro diagnostic devices which require plastic processing In vitro diagnostic devices which require non-metal mineral processing such as glass, ceramics In vitro diagnostic devices which require non-metal non-mineral processing such as textiles, rubber, leather, paper In vitro diagnostic devices which require the use of biotechnology In vitro diagnostic devices which require chemical processing In vitro diagnostic devices which require production of pharmaceuticals or knowledge regarding the production of pharmaceuticals In vitro diagnostic devices which require clean room production In vitro diagnostic devices which require processing of materials of human, animal or microbial origin In vitro diagnostic devices which require manufacture or processing of electronic components including communication devices In vitro diagnostic devices which require packaging, including labelling Komentář [VP20]: Rubber shall belong rather to the IVT 2002 In vitro diagnostic devices which require plastics and rubber processing, because chemically the same polymer can appear in plastic and elastic state, in dependency on the temperature and shear stress applied. (look on the literature regarding viscoelasticity and viscoelastic behaviour). Therefore, the separating of plastics and rubber into different codes is incorrect. (3) In vitro diagnostic devices which require specific knowledge in examination procedures IVP CODE IVP 3001 IVP 3002 In vitro diagnostic devices which require specific knowledge in examination procedures In vitro diagnostic devices which require knowledge regarding agglutination tests In vitro diagnostic devices which require knowledge regarding biochemistry EN 8 EN

9 IVP 3003 IVP 3004 IVP 3005 IVP 3006 IVP 3007 IVP 3008 IVP 3009 IVP 3010 IVP 3011 IVP 3012 IVP 3013 IVP 3014 In vitro diagnostic devices which require knowledge regarding chromatography In vitro diagnostic devices which require knowledge regarding chromosomal analysis In vitro diagnostic devices which require knowledge regarding coagulometry In vitro diagnostic devices which require knowledge regarding flow cytometry In vitro diagnostic devices which require knowledge regarding immunoassays In vitro diagnostic devices which require knowledge regarding lysis based testing In vitro diagnostic devices which require knowledge regarding measurement of radioactivity In vitro diagnostic devices which require knowledge regarding microscopy In vitro diagnostic devices which require knowledge regarding molecular biological testing including nucleic acid assays and next generation sequencing (NGS) In vitro diagnostic devices which require knowledge regarding physical chemistry including electrochemistry In vitro diagnostic devices which require knowledge regarding spectroscopy In vitro diagnostic devices which require knowledge regarding tests of cell function (4) In vitro diagnostic devices which require specific knowledge in laboratory and clinical disciplines for the purpose of product verification IVD CODE IVD 4100 IVD 4101 IVD 4102 IVD 4103 IVD 4104 In vitro diagnostic devices which require specific knowledge in laboratory and clinical disciplines for the purpose of product verification In vitro diagnostic devices which require knowledge regarding bacteriology - Multi-drug-resistant mycobacterium species (tuberculosis) - Vibrio cholerae (cholera) - Multi-resistant staphylococcus aureus (and/or tests for resistance genes) - Treponema pallidum (syphilis) IVD 4200 In vitro diagnostic devices which require knowledge regarding clinical chemistry / biochemistry IVD 4300 IVD 4301 IVD 4400 IVD 4500 In vitro diagnostic devices which require knowledge regarding detection of transmissible agents (without organisms or viruses) - Prion (Creutzfeldt-Jakob disease (CJD) and variant CJD (vcjd)) In vitro diagnostic devices which require knowledge regarding genetics In vitro diagnostic devices which require knowledge regarding haematology / haemostasis, including coagulation disorders EN 9 EN

10 IVD 4600 In vitro diagnostic devices which require knowledge regarding histocompatability and immunogenetics IVD 4700 In vitro diagnostic devices which require knowledge regarding immunohistochemistry / histology IVD 4800 In vitro diagnostic devices which require knowledge regarding immunology IVD 4900 In vitro diagnostic devices which require knowledge regarding molecular biology / diagnostics IVD 5000 IVD 5100 IVD 5101 IVD 5102 IVD 5103 IVD 5200 IVD 5201 IVD 5202 IVD 5203 IVD 5204 IVD 5205 IVD 5206 IVD 5207 IVD 5208 IVD 5209 IVD 5210 In vitro diagnostic devices which require knowledge regarding mycology In vitro diagnostic devices which require knowledge regarding parasitology - Plasmodium species (malaria) - Toxoplasma gondii (toxoplasmosis) - Trypanosoma cruzi (Chagas disease) In vitro diagnostic devices which require knowledge regarding virology - Cytomegalovirus (CMV IgG) - Epstein-Barr virus (EBV) - Hepatitis B, C, D, E - Highly virulent pandemic influenza - HIV 1 &2 (HIV/AIDS) - Human T-lymphotropic virus (HTLV) - SARS - coronavirus (SARS) - Lassa fever virus, Ebola virus, Marburg virus (viral haemorrhagic fevers) - West Nile virus (West Nile fever) - Zika virus (Zika fever) EN 10 EN

Applied-for scope of designation and notification of a Conformity Assessment Body Regulation (EU) 2017/746 (IVDR)

Applied-for scope of designation and notification of a Conformity Assessment Body Regulation (EU) 2017/746 (IVDR) Ref. Ares(2018)2576484-17/05/2018 NBOG s Best Practice Guide applicable for MDR IVDR NBOG F 2017-4 This document has been endorsed by the Medical Device Coordination Group (MDCG) established by Article

More information

This document is a preview generated by EVS

This document is a preview generated by EVS TECHNICAL SPECIFICATION ISO/TS 17822-1 First edition 2014-12-15 In vitro diagnostic test systems Qualitative nucleic acid-based in vitro examination procedures for detection and identification of microbial

More information

This document is a preview generated by EVS

This document is a preview generated by EVS EESTI STANDARD EVS-EN 13532:2002 Üldnõuded in vitro diagnostilistele enesekontrolli meditsiiniseadmetele General requirements for in vitro diagnostic medical devices for self-testing EESTI STANDARDIKESKUS

More information

31.0 Pathology Unit. Indian Health Facility Guidelines Introduction Planning

31.0 Pathology Unit. Indian Health Facility Guidelines Introduction Planning 31.0 Pathology Unit 31.1 Introduction 31.1.1 General The Pathology Unit provides facilities and equipment for the examination of body tissues and fluids, involving receipt of patient specimens, testing

More information

Aide mémoire for environmental conditions and treatment of biological models

Aide mémoire for environmental conditions and treatment of biological models I. Introduction This document was elaborated by experts and it is based on the current state of the art knowledge and OMCL in-house practices. The questions in the first column are addressed to the testing

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 1996L0022 EN 18.12.2008 002.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COUNCIL DIRECTIVE 96/22/EC of 29 April 1996 concerning

More information

BY TICKING YES TO ANY RULE ON THIS CHECKLIST YOU AGREE THAT THE FACILITY ALREADY COMPLIES WITH THAT STANDARD.

BY TICKING YES TO ANY RULE ON THIS CHECKLIST YOU AGREE THAT THE FACILITY ALREADY COMPLIES WITH THAT STANDARD. Veterinary Facility Evaluated: Rule 32: Animal Research Facilities NAME OF THE FACILITY: Please note: 32 (1) Application for facility registration must include a detailed description of the work that will

More information

Professional recognition for medical microbiology. Dr. K. Magerman Jessa Ziekenhuis Hasselt UHasselt

Professional recognition for medical microbiology. Dr. K. Magerman Jessa Ziekenhuis Hasselt UHasselt Professional recognition for medical microbiology Dr. K. Magerman Jessa Ziekenhuis Hasselt UHasselt In a European context UEMS (Union Européenne des Médecins Spécialistes) Section of Laboratory Medicine/Medical

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 1996L0022 EN 18.12.2008 002.001 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COUNCIL DIRECTIVE 96/22/EC of 29 April 1996 concerning

More information

Course Curriculum for Master Degree in Internal Medicine/ Faculty of Veterinary Medicine

Course Curriculum for Master Degree in Internal Medicine/ Faculty of Veterinary Medicine Course Curriculum for Master Degree in Internal Medicine/ Faculty of Veterinary Medicine The Master Degree in Internal Medicine/Faculty of Veterinary Medicine is awarded by the Faculty of Graduate Studies

More information

BY TICKING YES TO ANY RULE ON THIS CHECKLIST YOU AGREE THAT THE FACILITY ALREADY COMPLIES WITH THAT STANDARD.

BY TICKING YES TO ANY RULE ON THIS CHECKLIST YOU AGREE THAT THE FACILITY ALREADY COMPLIES WITH THAT STANDARD. Veterinary Facility Evaluated: Rule 25: Mobile animal services for private practitioners practicing from a registered physical veterinary facility and Compulsory Community Services facilities NAME OF THE

More information

COUNCIL REGULATION (EEC) No 2377/90

COUNCIL REGULATION (EEC) No 2377/90 -W- -- 18. 8. 90 Official Journal of the ~uroiean Communities No L 224/P - - (Acts whose publication is obligatory) COUNCIL REGULATION (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure

More information

ANNEXES. to the Proposal. for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

ANNEXES. to the Proposal. for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL EUROPEAN COMMISSION Brussels, XXX SANCO/12328/2013 Rev. 4 ANNEX (POOL/G1/2013/12328/12328R4-EN ANNEX.doc) [ ](2014) XXX draft ANNEXES 1 to 6 ANNEXES to the Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BTVPUR AlSap 1 suspension for injection for sheep and cattle. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose

More information

LIFE.2.B EUROPEAN UNION. Brussels, 14 November 2018 (OR. en) 2014/0255 (COD) PE-CONS 43/18 AGRILEG 102 VETER 52 CODEC 1149

LIFE.2.B EUROPEAN UNION. Brussels, 14 November 2018 (OR. en) 2014/0255 (COD) PE-CONS 43/18 AGRILEG 102 VETER 52 CODEC 1149 EUROPEAN UNION THE EUROPEAN PARLIAMT THE COUNCIL Brussels, 14 November 2018 (OR. en) 2014/0255 (COD) PE-CONS 43/18 AGRILEG 102 VETER 52 CODEC 1149 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: REGULATION

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS VIRBAGEN OMEGA - EN 1

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS VIRBAGEN OMEGA - EN 1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS VIRBAGEN OMEGA - EN 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Virbagen Omega 5 MU for dogs Virbagen Omega 10 MU for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

Error! Reference source not found. I. SUMMARY OF PRODUCT CHARACTERISTICS

Error! Reference source not found. I. SUMMARY OF PRODUCT CHARACTERISTICS PRODUCTNAME NOBIVAC RABIES 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac Rabies 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active components: Rabies strain Pasteur RIV; at least 2 I.U. per dose

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 2003L0099 EN 01.01.2007 001.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B DIRECTIVE 2003/99/EC OF THE EUROPEAN PARLIAMENT

More information

COMMISSION (2003/708/EC)

COMMISSION (2003/708/EC) 10.10.2003 L 258/11 COMMISSION COMMISSION DECISION of 7 October 2003 amending Annex E to Council Directive 91/68/EEC and Annexes I and II to Decision 93/198/EEC as regards the updating of the model health

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BLUEVAC BTV8 suspension for injection for cattle and sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Oncept IL-2 lyophilisate and solvent for suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 16.6.2009 COM(2009) 268 final 2009/0077 (COD) C7-0035/09 Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC)

More information

Physician Veterinarian Do you have the Bayer Spirit?

Physician Veterinarian Do you have the Bayer Spirit? CropScience HealthCare MaterialScience Business Services Industry Services Technology Services www.mybayerjob.com Physician Veterinarian Do you have the Bayer Spirit? Research and Development, Occupational

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT CLYNAV solution for injection for Atlantic salmon 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 0.05 ml dose

More information

Veterinary Medicine - VMED

Veterinary Medicine - VMED Veterinary Medicine - VMED 1 Veterinary Medicine - VMED Courses VMED 7230 CUTANEOUS DISORDERS OF LARGE AND EXOTIC ANIMALS (3) LEC. 3, IND/LEC. 9-12. In depth review of the common and uncommon dermatologic

More information

Why Don t These Drugs Work Anymore? Biosciences in the 21 st Century Dr. Amber Rice October 28, 2013

Why Don t These Drugs Work Anymore? Biosciences in the 21 st Century Dr. Amber Rice October 28, 2013 Why Don t These Drugs Work Anymore? Biosciences in the 21 st Century Dr. Amber Rice October 28, 2013 Outline Drug resistance: a case study Evolution: the basics How does resistance evolve? Examples of

More information

Analogous application of the GDP Guidelines 2013/C 343/01 for veterinary medicinal products

Analogous application of the GDP Guidelines 2013/C 343/01 for veterinary medicinal products Analogous application of the GDP Guidelines 2013/C 343/01 for veterinary medicinal products Document valid as of: 01.01.2016 Document number: I-SMI.TI.19e Version 01 Classification: public Replaces document:

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AMPROLINE 400 mg/ml solution for use in drinking water for chickens and turkeys 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.

More information

SOFT Movement Survey of FMT Programs

SOFT Movement Survey of FMT Programs Appendix 1 (as supplied by the authors): Survey SOFT Movement Survey of FMT Programs Part 1: General Information about your Fecal Microbiota Transplant (FMT) Program 1) Please fill out the information

More information

METRIGUARD. Technical Bulletin

METRIGUARD. Technical Bulletin METRIGUARD Technical Bulletin Metriguard is a general purpose disinfectant intended for use in cleaning, decontaminating and disinfecting equipment surfaces and non-critical instruments in hospitals, laboratories,

More information

Course Curriculum for Master Degree Theriogenology & Artificial Insemination/Faculty of Veterinary Medicine

Course Curriculum for Master Degree Theriogenology & Artificial Insemination/Faculty of Veterinary Medicine Course Curriculum for Master Degree Theriogenology & Artificial Insemination/Faculty of Veterinary Medicine The Master Degree in Theriogenology & Artificial Insemination /Faculty of Veterinary Medicine

More information

Irish Medicines Board

Irish Medicines Board IRISH MEDICINES BOARD ACT 1995, as amended European Communities (Animal Remedies) (No. 2) Regulations 2007 VPA: 10999/033/001A Case No: 7006569 The in exercise of the powers conferred on it by Animal Remedies

More information

E-BOOK # BACTERIAL DISEASES IN HUMANS EBOOK

E-BOOK # BACTERIAL DISEASES IN HUMANS EBOOK 15 November, 2017 E-BOOK # BACTERIAL DISEASES IN HUMANS EBOOK Document Filetype: PDF 475.49 KB 0 E-BOOK # BACTERIAL DISEASES IN HUMANS EBOOK Communicable diseases, also known as infectious diseases or

More information

Approved by the Food Safety Commission on September 30, 2004

Approved by the Food Safety Commission on September 30, 2004 Approved by the Food Safety Commission on September 30, 2004 Assessment guideline for the Effect of Food on Human Health Regarding Antimicrobial- Resistant Bacteria Selected by Antimicrobial Use in Food

More information

VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS

VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS A61D VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS Apparatus (i.e. instruments, implements, machines, structures, tools) or processes for enhancing or controlling the breeding of companion, domesticated,

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 2001R0999 EN 17.11.2012 036.001 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B REGULATION (EC) No 999/2001 OF THE EUROPEAN PARLIAMENT

More information

2012 No. 153 ANIMALS

2012 No. 153 ANIMALS STATUTORY RULES OF NORTHERN IRELAND 2012 No. 153 ANIMALS ANIMAL WELFARE The Welfare of Animals (Permitted Procedures by Lay Persons) Regulations (Northern Ireland) 2012 Laid before the Assembly in draft

More information

Veterinary Medical Terminology

Veterinary Medical Terminology Curriculum Outline: Course # Required courses prior to admission Credit hours BIO 0 Principles of Biology I with Lab 4 CHM 0 General Chemistry I with Lab 4 ENG 110 or 111 or 1 Freshman Composition or Composition

More information

VETERINARY MEDICINE-VM (VM)

VETERINARY MEDICINE-VM (VM) Veterinary Medicine-VM (VM) 1 VETERINARY MEDICINE-VM (VM) Courses VM 603 Veterinary Science: Research and Methods Credit: 1 (1-0-0) Course Description: Conduct of responsible research, contributions of

More information

SOUTH AFRICAN NATIONAL STANDARD

SOUTH AFRICAN NATIONAL STANDARD ISBN 978-0-626-35881-5 SOUTH AFRICAN NATIONAL STANDARD Pet food Nutritional and manufacturing requirements WARNING This document references other documents normatively. Published by the South African Bureau

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT COXEVAC suspension for injection for cattle and goats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:

More information

10015NAT Graduate Diploma Veterinary Acupuncture

10015NAT Graduate Diploma Veterinary Acupuncture 10015NAT Graduate Diploma Veterinary Acupuncture Nationally accredited under the Australian Qualifications Framework at postgraduate level. WHO IS IT FOR? The 10015NAT Graduate Diploma Veterinary Acupuncture

More information

Having regard to the Treaty establishing the European Community, and in particular Article 152(4)(b) thereof,

Having regard to the Treaty establishing the European Community, and in particular Article 152(4)(b) thereof, 12.12.2003 L 325/31 DIRECTIVE 2003/99/EC OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 17 November 2003 on the monitoring of zoonoses and zoonotic agents, amending Council Decision 90/424/EEC and repealing

More information

Course Curriculum for Master Degree in Poultry Diseases/Veterinary Medicine

Course Curriculum for Master Degree in Poultry Diseases/Veterinary Medicine Course Curriculum for Master Degree in Poultry Diseases/Veterinary Medicine The Master Degree in Poultry Diseases /Veterinary Medicine, is awarded by the Faculty of Graduate Studies at Jordan University

More information

Course # Course Name Credits

Course # Course Name Credits Curriculum Outline: Course # Course Name Credits Term 1 Courses VET 100 Introduction to Veterinary Technology 3 ENG 105 English Composition 3 MATH 120 Technical Mathematics 3 VET 130 Animal Biology/ Anatomy

More information

Clinical Programme. Dermatology

Clinical Programme. Dermatology 2018 The diagnosis and management of skin represents a major component of small animal practice. Through lectures, case discussions and practical sessions, this modular programme will enable you to learn

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AT, BE, CZ, EE, ES, FR, IE, IS, IT, LT, LU, LV, NO, PL, PT, RO, SE, SI, SK, UK: Genestran 75 micrograms/ml solution for injection

More information

American Association of Feline Practitioners American Animal Hospital Association

American Association of Feline Practitioners American Animal Hospital Association American Association of Feline Practitioners American Animal Hospital Association Basic Guidelines of Judicious Therapeutic Use of Antimicrobials August 1, 2006 Introduction The Basic Guidelines to Judicious

More information

(Non-legislative acts) REGULATIONS

(Non-legislative acts) REGULATIONS 8.9.2010 Official Journal of the European Union L 237/1 II (Non-legislative acts) REGULATIONS COMMISSION REGULATION (EU) No 790/2010 of 7 September 2010 amending Annexes VII, X and XI to Regulation (EC)

More information

Official Journal of the European Union

Official Journal of the European Union 11.6.2003 L 143/23 COUNCIL DIRECTIVE 2003/43/EC of 26 May 2003 amending Directive 88/407/EEC laying down the animal health requirements applicable to intra- Community trade in and imports of semen of domestic

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Covexin 10 Suspension for injection for sheep and cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Potency

More information

Having regard to the Treaty establishing the European Community, and in particular Article 152(4)(b) thereof,

Having regard to the Treaty establishing the European Community, and in particular Article 152(4)(b) thereof, 14.10.2003 L 262/17 DIRECTIVE 2003/74/EC OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 22 September 2003 amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain

More information

Annex 18 The Safe Transport of Dangerous Goods by Air

Annex 18 The Safe Transport of Dangerous Goods by Air Annex 18 The Safe Transport of Dangerous Goods by Air Katherine Rooney Cargo Safety Section What are dangerous goods? Articles or substances which are capable of posing a risk to health, safety, property

More information

Zoonoses: Austria Dr. Ulrich Herzog World Health Day Foodsafety AGES

Zoonoses: Austria Dr. Ulrich Herzog World Health Day Foodsafety AGES Zoonoses: Austria 2005-2014 Dr. Ulrich Herzog World Health Day 2015 - Foodsafety 07.04.2015 - AGES Overview Legal Background - EU / Austria Development in Austria Outlook challenges for the future Summary

More information

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 20.1.2005 COM(2005) 7 final. REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT FOURTH REPORT ON THE STATISTICS ON THE NUMBER OF ANIMALS

More information

KESMAVET. Disiapkan oleh Prof.Dr.Pratiwi Ts, drh,ms. kesmavet 1-pts

KESMAVET. Disiapkan oleh Prof.Dr.Pratiwi Ts, drh,ms. kesmavet 1-pts KESMAVET Disiapkan oleh Prof.Dr.Pratiwi Ts, drh,ms 1 Generated by Foxit PDF Creator Foxit Software In One World we share: - Air - Water - Land - Food - Pathogens - Toxins 2 ONE MEDICINE 3 ONE PATHOLOGY!!!

More information

L 210/36 Official Journal of the European Union DECISIONS COMMISSION

L 210/36 Official Journal of the European Union DECISIONS COMMISSION L 210/36 Official Journal of the European Union 10.8.2007 II (Acts adopted under the EC Treaty/Euratom Treaty whose publication is not obligatory) DECISIONS COMMISSION COMMISSION DECISION of 9 August 2007

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12 1. NAME OF THE VETERINARY MEDICINAL PRODUCT HALOCUR 0.5 mg/ml oral solution for calves 2. Qualitative and quantitative composition Active substance Halofuginone

More information

ECTS II. semester Anatomy with Organogenesis of Domestic Animals II.

ECTS II. semester Anatomy with Organogenesis of Domestic Animals II. 1 st year I. semester Physics and Biophysics 16 0 38 0 5 Medical Chemistry 20 0 34 0 5 Zoology 15 20 40 0 5,5 Botany in Veterinary Medicine 10 0 10 0 1,5 Anatomy with Organogenesis of Domestic 18 0 64

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis ColiClos suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml

More information

Scientific Discussion post-authorisation update for Rheumocam extension X/007

Scientific Discussion post-authorisation update for Rheumocam extension X/007 5 May 2011 EMA/170257/2011 Veterinary Medicines and Product Data Management Scientific Discussion post-authorisation update for Rheumocam extension X/007 Scope of extension: addition of 20 mg/ml solution

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS Revised: January 2012 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Blackleg Vaccine 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance(s): per ml Five strains

More information

TABLE OF CONTENTS. 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process

TABLE OF CONTENTS. 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process TABLE OF CONTENTS Winnipeg Regional Health Authority Introduction Page Number 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process 2. WRHA Infection Prevention and Control

More information

DG(SANCO)/ MR

DG(SANCO)/ MR 1 The CA should finalise guidelines for official controls on the aquaculture sector in order to be able to check that the requirements in Articles 4 and 5 of the Directive are implemented in a harmonised

More information

(Text with EEA relevance)

(Text with EEA relevance) L 225/76 19.8.2016 COMMISSION REGULATION (EU) 2016/1396 of 18 August 2016 amending certain Annexes to Regulation (No 999/2001 of the European Parliament and of the Council laying down rules for the prevention,

More information

Women s Antimicrobial Guidelines Summary

Women s Antimicrobial Guidelines Summary Women s Antimicrobial Guidelines Summary 1. Introduction and Who Guideline applies to This guideline has been developed to deliver safe and appropriate empirical use of antibiotics for patients at University

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Eurican Herpes 205 powder and solvent for emulsion for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active

More information

Dr. P. P. Doke. M.D., D.N.B., Ph.D., FIPHA. Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune

Dr. P. P. Doke. M.D., D.N.B., Ph.D., FIPHA. Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune Dr. P. P. Doke M.D., D.N.B., Ph.D., FIPHA Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune 1 Anti microbial resistance is now a global geometrically increasing threat

More information

UNIVERSITY OF PITTSBURGH Institutional Animal Care and Use Committee

UNIVERSITY OF PITTSBURGH Institutional Animal Care and Use Committee UNIVERSITY OF PITTSBURGH Institutional Animal Care and Use Committee Policy: Surgical Guidelines EFFECTIVE ISSUE DATE: 2/21/2005 REVISION DATE(s): 2/14/15; 3/19/2018 SCOPE To describe guidelines and considerations

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Maprelin 75 µg/ml solution for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution for injection

More information

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products Quality of Veterinary Medicinal Products How to ensure the quality of Veterinary Medicinal Products Gérard Moulin Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products gerard.moulin@anses.fr

More information

Shall be kept clean and in good repair. (a) maintained on every animal and be legibly and accurately documented in a timely manner

Shall be kept clean and in good repair. (a) maintained on every animal and be legibly and accurately documented in a timely manner 930-X-1-.32 Minimum Standards For Mobile Premises. The minimum standards for all mobile premise facilities in which veterinary medicine is practiced shall be as follows: (1) General facility: Shall be

More information

DIRECTIVE 2001/82/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 6 November 2001 on the Community code relating to veterinary medicinal products

DIRECTIVE 2001/82/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 6 November 2001 on the Community code relating to veterinary medicinal products 2001L0082 EN 07.08.2009 004.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B DIRECTIVE 2001/82/EC OF THE EUROPEAN PARLIAMENT

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2018)2119965-20/04/2018 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health and food audits and analysis DG(SANTE) 2017-6296 FINAL REPORT OF AN AUDIT CARRIED OUT IN DENMARK

More information

(Non-legislative acts) DECISIONS

(Non-legislative acts) DECISIONS EN 5.6.2012 Official Journal of the European Union L 145/1 II (Non-legislative acts) DECISIONS COMMISSION IMPLEMENTING DECISION of 22 May 2012 amending Decision 2008/425/EC as regards standard requirements

More information

The European Union Reference Laboratories network

The European Union Reference Laboratories network The European Union Reference Laboratories network Structure, objectives and responsibilities of the European reference laboratory system responsibilities in case of a crisis Frank Swartenbroux European

More information

[Version 8, 10/2012] SUMMARY OF PRODUCT CHARACTERISTICS

[Version 8, 10/2012] SUMMARY OF PRODUCT CHARACTERISTICS [Version 8, 10/2012] SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Curofen 50 mg/g Premix for Medicated Feeding Stuff for Pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCPCh lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

National Competent Authorities for the implementation of Directive 2010/63/EU on the protection of animals used for scientific purposes

National Competent Authorities for the implementation of Directive 2010/63/EU on the protection of animals used for scientific purposes National Competent Authorities for the implementation of Directive 2010/63/EU on the protection of animals used for scientific purposes Working document on specific articles in Directive 2010/63/EU Brussels,

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/728/00-FINAL April 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS STREPTOMYCIN AND

More information

DEPARTMENT OF MEDICAL MICROBIOLOGY

DEPARTMENT OF MEDICAL MICROBIOLOGY 1. Title of Subject: Tumor viruses and oncogenes DEPARTMENT OF MEDICAL MICROBIOLOGY semester: 2 nd Coordinator: Dr. György Veress Instructors: Dr. György Veress Entrance conditions: Final exam from Medical

More information

MICRO-ORGANISMS by COMPANY PROFILE

MICRO-ORGANISMS by COMPANY PROFILE MICRO-ORGANISMS by COMPANY PROFILE 2017 1 SAPROPHYTES AND PATHOGENES SAPROPHYTES Not dangerous PATHOGENES Inducing diseases Have to be eradicated WHERE ARE THERE? EVERYWHERE COMPANY PROFILE 2017 3 MICROORGANISMS

More information

COMMISSION IMPLEMENTING REGULATION (EU)

COMMISSION IMPLEMENTING REGULATION (EU) EN L 186/20 Official Journal of the European Union 14.7.2012 COMMISSION IMPLEMENTING REGULATION (EU) No 637/2012 of 13 July 2012 amending Implementing Regulation (EU) No 540/2011 as regards the conditions

More information

Procedures for the Taking of Prevention and Eradication Measures of Brucellosis in Bovine Animals

Procedures for the Taking of Prevention and Eradication Measures of Brucellosis in Bovine Animals Republic of Latvia Cabinet Regulation No. 881 Adopted 18 December 2012 Procedures for the Taking of Prevention and Eradication Measures of Brucellosis in Bovine Animals Issued in accordance with Section

More information

SGV POLICY ON THE TRANSPORT OF INJURED GREYHOUNDS

SGV POLICY ON THE TRANSPORT OF INJURED GREYHOUNDS SGV POLICY ON THE TRANSPORT OF INJURED GREYHOUNDS The Society of Greyhound Veterinarians has produced this document to aid decision making by track vets, and to increase awareness of the new EU Transport

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE European Medicines Agency Veterinary Medicines and Inspections EMEA/CVMP/211249/2005-FINAL July 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE DIHYDROSTREPTOMYCIN (Extrapolation to all ruminants)

More information

The Regulation of medical devices in the European Union

The Regulation of medical devices in the European Union 11 May, Geneva The Regulation of medical devices in the European Union Carlo Pettinelli Director European Commission DG Internal Market, Industry, Entrepreneurship and SMEs 1 The EU single market for medical

More information

Rules 18 23;24 and 6: Minimum Standards for Clinical Veterinary Facilities

Rules 18 23;24 and 6: Minimum Standards for Clinical Veterinary Facilities Veterinary Facility Evaluated: Rules 18 23;24 and 6: Minimum Standards for Clinical Veterinary Facilities NAME OF THE FACILITY AND REGISTRATION NUMBER: BY TICKING YES TO ANY RULE ON THIS CHECKLIST YOU

More information

GUIDELINES. Ordering, Performing and Interpreting Laboratory Tests in Veterinary Clinical Practice

GUIDELINES. Ordering, Performing and Interpreting Laboratory Tests in Veterinary Clinical Practice GUIDELINES Ordering, Performing and Interpreting Laboratory Tests in Veterinary Clinical Practice Approved by Council: January 31, 2007; March 21, 2012 Publication Date: March 2007 (Update); February 2007

More information

VETERINARY SCIENCE CURRICULUM. Unit 1: Safety and Sanitation

VETERINARY SCIENCE CURRICULUM. Unit 1: Safety and Sanitation Chariho Regional School District - Science Curriculum September, 2016 VETERINARY SCIENCE CURRICULUM Unit 1: Safety and Sanitation Students will gain an understanding of the types of hazards common in veterinary

More information

Cleaning & Sanitising Medical range. Working in harmony with nature to protect

Cleaning & Sanitising Medical range. Working in harmony with nature to protect Cleaning & Sanitising Medical range Working in harmony with nature to protect Introduction Hospitals, nursing homes and similar establishments are now acknowledged to have a major pathogenic problem Methicillin

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection SUMMARY OF PRODUCT CHARACTERISTICS Revised: June 2018 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

Animal User Group Meeting Fall Discussion Topics

Animal User Group Meeting Fall Discussion Topics Animal User Group Meeting Fall 2016 Below are key summary points from the Animal User Group Meetings hosted by ULAM Faculty Veterinarians in September 2016. It is our practice not to share slides from

More information

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NUFLOR 300 mg/ml solution for injection for cattle and sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Pentofel 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 1ml: Active components Inactivated Feline Panleukopenia

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC FOR ANTIMICROBIAL PRODUCTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC FOR ANTIMICROBIAL PRODUCTS European Medicines Agency Veterinary Medicines and Inspections London, 12 November 2007 EMEA/CVMP/SAGAM/383441/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC

More information

Feline Immunodeficiency Virus (FIV)

Feline Immunodeficiency Virus (FIV) Virus (FeLV) FIV and FeLV are both viruses within the same family of retroviruses, but they are in different groups within that family: FIV is in one group called lentiviruses these cause lifelong infections

More information

INFECTIOUS HEPATITIS, PARVOVIRUS & DISTEMPER

INFECTIOUS HEPATITIS, PARVOVIRUS & DISTEMPER Canine VacciCheck INFECTIOUS HEPATITIS, PARVOVIRUS & DISTEMPER IgG ANTIBODY TEST KIT INSTRUCTION MANUAL Sufficient for 12/120 assays 13 JUL 2015 Biogal Galed Laboratories Acs. Ltd., tel: 972-4-9898605.

More information

Antibacterial Agents & Conditions. Stijn van der Veen

Antibacterial Agents & Conditions. Stijn van der Veen Antibacterial Agents & Conditions Stijn van der Veen Antibacterial agents & conditions Antibacterial agents Disinfectants: Non-selective antimicrobial substances that kill a wide range of bacteria. Only

More information